- Product Description Description
- Table of Contents TOC
- List of Table & Figure LOT
- Get Free Sample PDF Sample PDF
Market Size, 2025
$3.80 BnMarket Estimate, 2026
$4.34 BnMarket Forecast, 2034
$12.64 BnCAGR, 2026–2034
14.3%European Bioinformatics Market Size, Growth, Trends & Forecast (2026–2034)
The European bioinformatics market size was valued at USD 3.80 billion in 2025, reached USD 4.34 billion in 2026, and is anticipated to reach USD 12.64 billion by 2034, growing at a compound annual growth rate (CAGR) of 14.3% during the forecast period from 2026 to 2034. Propelled by the growing need for nucleic acid and protein sequencing, rising clinical diagnostic integration, increasing government initiatives, and expanding research partnerships, the regional market demonstrates rapid expansion.
Key Executive Metrics (At-a-Glance)
- 2025 Base Valuation: USD 3.80 Billion
- 2026 Current Valuation: USD 4.34 Billion
- 2034 Forecast Valuation: USD 12.64 Billion
- Compound Annual Growth Rate (CAGR): 14.3% (2026–2034)
- Dominant Country Leader: Germany (Projected to hold the highest market share)
- Fastest-Growing Countries: France and the U.K. (Expected to expand at the highest CAGRs during the forecast period)
Core Market Drivers & Growth Triggers
- Sequencing & Medicine Development: Escalating demand for protein and nucleic acid sequencing to assist in manufacturing novel medicines and clinical diagnostics.
- Systems Integration: Rising adoption of integrated bioinformatics platforms across genomics, proteomics, and advanced user tools.
Primary Market Restraints & Challenges
- Technical Hurdles: High costs, a scarcity of skilled workers, a lack of user-friendly tools, and data format interoperability issues.
European Bioinformatics Market Segmentation Breakdown
| Segment Category | Key Segment Options / Focus Areas |
|---|---|
| By Sector | Animal Biotechnology, Environmental Biotechnology, Agricultural Biotechnology, Forensic Biotechnology, Medical Biotechnology (Drug Development, Clinical Diagnostics, Personalized Medicine), Academics, and Others |
| By Products and Services | Bioinformatics Platforms (Sequence analysis, alignment, manipulation, structural/functional analysis), Knowledge Management Tools, Bioinformatics Services (Data analysis, sequencing), and Database & Management Services |
| By Application | Proteomics, Transcriptomics, Molecular Phylogenetics, Chemoinformatics, Drug Design, and Genomics |
| By Country | UK, France, Spain, Germany (Leader), Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic, and Rest of Europe |
Major Industry Players Profiled
Key corporations shaping the European bioinformatics market include Agilent Technologies, Inc., Affymetrix, Inc., Applied Biological Materials (ABM) Inc., 3rd Millennium, Inc., Illumina, Inc., Thermo Fisher Scientific Inc., QIAGEN N.V., Biomax Informatics AG, DNAnexus, Inc., and Waters Corporation.
Europe Bioinformatics Market Size
The European bioinformatics market size was valued at USD 3.80 billion in 2025 and is anticipated to reach USD 4.34 billion in 2026 from USD 12.64 billion by 2034, growing at a CAGR of 14.3%. During the forecast period from 2026 to 2034.
Bioinformatics is a field of study in which biological data is interpreted through the development and use of new software tools and methods. It is an interdisciplinary field comprising engineering, mathematics, statistics, and computer science to analyze the biological information acquired—bioinformatics envelops all the biological studies done using computer programming as the tool. Bioinformatics is most often used for knowing candidate genes and single nucleotide polymorphisms.
Bioinformatics is used in quite a few areas of biology. It helps in obtaining useful information from the text and in gene ontology to organize and name data. In the field of genomics and genetics, assists in sequencing genomes and noting their mutations. It is useful in understanding evolutionary aspects of molecular biology by comparing genetic and genomic data. In experimental molecular biology, it proves very useful because of techniques such as image and signal processing. It also helps in analyzing gene and protein expression and regulation.
The driving factors of the European Bioinformatics market are the growing need for sequencing protein and nucleic acids, rising assistance of this field in manufacturing new medicines and clinical diagnostics, increasing initiatives from the government, rising demand for integrated bioinformatics systems in proteomics and genomics, an increasing number of partnerships between research organizations and companies among others.
The constraints of this market are high costs, lack of skilled workers, lack of user-friendly tools, and lack of interoperability among various data formats.
Regionally, the European market was the second-largest market in the world in 2022. Factors such as the increased need for protein and nucleic acid sequencing, increasing funding for research, and technological advancements are expected to propel the growth of this market in the region.
During the forecast period, the German bioinformatics market is expected to have the highest shares of the European Bioinformatics market and the bioinformatics market in France and the U.K., which are expected to increase in the forecast period with the highest CAGR. Increasing disposable income in the countries and the adoption of new technologies from the users are likely to bolster the market demand. Also, the end-users increasing use of advanced tools is expected to boost the Bioinformatics growth in the forecast period.
KEY MARKET PLAYERS
Some of the key market participants operating in the European Bioinformatics Market include
- Agilent Technologies, Inc. (U.S.)
- Affymetrix, Inc. (U.S.)
- Applied Biological Materials (ABM) Inc. (Canada)
- 3rd Millennium, Inc. (U.S.)
- Illumina, Inc. (U.S.)
- Thermo Fisher Scientific Inc. (U.S.)
- QIAGEN N.V. (Netherlands)
- Biomax Informatics AG (Germany)
- DNAnexus, Inc. (U.S.)
- Waters Corporation (U.S.)
MARKET SEGMENTATION
This research report on the European Bioinformatics Market has been segmented & sub-segmented into the following categories
By Sector
- Animal Biotechnology
- Environmental Biotechnology
- Alternative Energy Sources
- Waste Clean-Up/Bioremediation
- Climate Change Studies
- Agricultural Biotechnology
- Crop Yield Improvement
- Pest Resistance
- Improvement of Plant Resistance
- Biodiversity Informatics
- Nutritional Quality Improvement
- Forensic Biotechnology
- Medical Biotechnology
- Drug Development
- Clinical Diagnostics
- Molecular Medicine
- Personalized Medicine
- Preventive Medicine
- Gene Therapy
- Reproductive Biotechnology
- Academics
- Other Sectors
By-Products and Services
- Bioinformatics Platforms
- Sequence Analysis Platforms
- Sequence Alignment Platforms
- Sequence Manipulation Platforms
- Structural and Functional Analysis Platforms
- Other Bioinformatics Platforms
- Knowledge Management Tools
- Generalized Knowledge Management Tools
- Specialized Knowledge Management Tools
- Bioinformatics Services
- Data Analysis
- Sequencing Services
- Other Bioinformatics Services
- Database and Management Services
By Application
- Proteomics
- Transcriptomics
- Molecular Phylogenetics
- Chemoinformatics
- Drug Design
- Genomics
By Country
- UK
- France
- Spain
- Germany
- Italy
- Russia
- Sweden
- Denmark
- Switzerland
- Netherlands
- Turkey
- Czech Republic
- Rest of Europe